Bionomics Limited Top Insiders

BNOEFDelisted Stock  USD 0.01  0.00  0.00%   
Bionomics employs about 22 people. The company is managed by 5 executives with a total tenure of roughly 6 years, averaging almost 1.0 years of service per executive, having 4.4 employees per reported executive. Examination of Bionomics' management performance can provide insight into the company performance.
DCPSA FFPM  Insider
Consultant Neuroscience
Errol Souza  Director
Non-Executive Director
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

Bionomics Management Team Effectiveness

The company has return on total asset (ROA) of (0.184) % which means that it has lost $0.184 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4164) %, meaning that it generated substantial loss on money invested by shareholders. Bionomics' management efficiency ratios could be used to measure how well Bionomics manages its routine affairs as well as how well it operates its assets and liabilities.

Bionomics Workforce Comparison

Bionomics Limited is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 55.0. Bionomics totals roughly 22.0 in number of employees claiming about 40% of stocks in Biotechnology industry.

Bionomics Notable Stakeholders

A Bionomics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Bionomics often face trade-offs trying to please all of them. Bionomics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Bionomics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Errol SouzaNon-Executive DirectorProfile
DCPSA FFPMConsultant NeuroscienceProfile
FCA BECActing OfficerProfile
FCIS BComCompany SecProfile
Connor MScVP DevelProfile

About Bionomics Management Performance

The success or failure of an entity such as Bionomics Limited often depends on how effective the management is. Bionomics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Bionomics management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Bionomics management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia. Bionomics is traded on OTC Exchange in the United States.

Bionomics Workforce Analysis

Traditionally, organizations such as Bionomics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Bionomics within its industry.

Bionomics Manpower Efficiency

Return on Bionomics Manpower

Revenue Per Employee12K
Revenue Per Executive52.7K
Net Loss Per Employee989.1K
Net Loss Per Executive4.4M
Working Capital Per Employee2.1M
Working Capital Per Executive9.4M
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Consideration for investing in Bionomics Pink Sheet

If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments